A bacterial protein recently thought to be a unique mechanism for utilizing iron may not be after all. Researchers from the University of Georgia, the Fellowship for Interpretation of Genomes, the University of Oklahoma and the University of Utah School of Medicine report their findings in the latest issue of the online journal mBio.
The ability to acquire iron from their host is an important factor in the ability of bacteria to establish an infection. The major source of host iron in infections is heme, a component of hemoglobin and disease-causing bacteria have evolved complex mechanisms to acquire the heme and extract the iron. In the case of E. coli bacteria recent research has reported that the bacterial protein YfeX is able to remove iron from heme using a process called dechelation and leave an intact tetrapyrrole. This is totally unlike any other described biological system for iron removal from heme and, thus, would represent a dramatically new feature with potentially profound implications for understanding how bacteria cause disease.
Based on the gene sequences responsible for its production, this compound appears to be a dye-decolorizing peroxidase (DyP), a relatively recently recognized superfamily of heme-containing peroxidases that are found in fungi and bacteria.
"Given the diversity of organisms that possess DyP-type proteins, the identification of this class of proteins as heme dechelatases would have profound physiological and environmental implications. Because of this and our interest in heme metabolism, we undertook to examine in more detail the protein YfeX," write the researchers.
In the study, they propose and demonstrate that YfeX is a typical DyP with no ability to dechelate iron from heme.
"The data presented herein demonstrate that recombinant YfeX is a typical DyP-type peroxidase and does not possess the catalytic ability to dechelate iron from heme in vitro," write the researchers. "In vivo experiments with YfeX in E. coli and its homolog in Vibrio fischeri revealed no evidence that YfeX either is involved in iron acquisition from heme or generates prophyrin from exogenously supplied heme."
APIC Salutes 2025 Trailblazers in Infection Prevention and Control
June 18th 2025From a lifelong mentor to a rising star, the Association for Professionals in Infection Control and Epidemiology (APIC) honored leaders across the career spectrum at its 2025 Annual Conference in Phoenix, recognizing individuals who enhance patient safety through research, leadership, and daily practice.
Building Infection Prevention Capacity in the Middle East: A 7-Year Certification Success Story
June 17th 2025Despite rapid development, the Middle East faces a critical shortage of certified infection preventionists. A 7-year regional initiative has significantly boosted infection control capacity, increasing the number of certified professionals and elevating patient safety standards across health care settings.
Streamlined IFU Access Boosts Infection Control and Staff Efficiency
June 17th 2025A hospital-wide quality improvement project has transformed how staff access critical manufacturer instructions for use (IFUs), improving infection prevention compliance and saving time through a standardized, user-friendly digital system supported by unit-based training and interdepartmental collaboration.
Swift Isolation Protocol Shields Chicago Children’s Hospital During 2024 Measles Surge
June 17th 2025When Chicago logged its first measles cases linked to crowded migrant shelters last spring, one pediatric hospital moved in hours—not days—to prevent the virus from crossing its threshold. Their playbook offers a ready template for the next communicable-disease crisis.